Controversial Turing Pharmaceuticals CEO Martin Shkreli, who was charged Thursday with securities fraud, has resigned his position and will be replaced, in the interim, by board chairman Ron Tilles.
Source:CBC | Business News http://ift.tt/1IdDddz
Controversial Turing Pharmaceuticals CEO Martin Shkreli, who was charged Thursday with securities fraud, has resigned his position and will be replaced, in the interim, by board chairman Ron Tilles.
0 commentaires:
Enregistrer un commentaire